Largazole inhibits ocular angiogenesis by modulating the expression of VEGFR2 and p21
Ocular angiogenic diseases, characterized by abnormal blood vessel formation in the eye, are the leading cause of blindness. Although Anti-VEGF therapy is the first-line treatment in the market, a substantial number of patients are refractory to it or may develop resistance over time. As uncontrolle...
Saved in:
Main Authors: | Qiu, Beiying, Tan, Alison, Tan, Yu Zhi, Chen, Qi-Yin, Luesch, Hendrik, Wang, Xiaomeng |
---|---|
Other Authors: | Lee Kong Chian School of Medicine (LKCMedicine) |
Format: | Article |
Language: | English |
Published: |
2022
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/154015 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Complement factor B mediates ocular angiogenesis through regulating the VEGF signaling pathway
by: Murray, Hannah, et al.
Published: (2022) -
Isthmin is a novel secreted angiogenesis inhibitor that inhibits tumour growth in mice
by: Xiang, W., et al.
Published: (2014) -
Modeling the origin of the ocular pulse and its impact on the optic nerve head
by: Jin, Yuejiao, et al.
Published: (2018) -
A role of Agrin in maintaining the stability of vascular endothelial growth factor receptor-2 during tumor angiogenesis
by: Njah, Kizito, et al.
Published: (2019) -
S100A proteins as molecular targets in the ocular surface inflammatory diseases
by: Tong, L., et al.
Published: (2014)